| __timestamp | Ionis Pharmaceuticals, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 1860000 |
| Thursday, January 1, 2015 | 37173000 | 2963000 |
| Friday, January 1, 2016 | 48616000 | 6961000 |
| Sunday, January 1, 2017 | 108488000 | 11779000 |
| Monday, January 1, 2018 | 244622000 | 13697000 |
| Tuesday, January 1, 2019 | 287000000 | 15749000 |
| Wednesday, January 1, 2020 | 354000000 | 18638000 |
| Friday, January 1, 2021 | 186000000 | 27196000 |
| Saturday, January 1, 2022 | 151000000 | 31739000 |
| Sunday, January 1, 2023 | 232600000 | 33491000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing expenses is crucial for success. Ionis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, Ionis has seen its Selling, General, and Administrative (SG&A) expenses grow by over 1,000%, peaking in 2020. This reflects their aggressive expansion and investment in new therapies. In contrast, Protagonist Therapeutics, while also increasing its SG&A expenses, has maintained a more modest growth rate, with a 1,700% increase since 2014. This suggests a more cautious approach, focusing on sustainable growth. By 2023, Ionis's expenses were nearly seven times higher than Protagonist's, highlighting their differing strategies. As these companies continue to evolve, their financial strategies will be key indicators of their future success.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Protagonist Therapeutics, Inc.
Zoetis Inc. and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Protagonist Therapeutics, Inc.
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Halozyme Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. vs Opthea Limited: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. vs Merus N.V.: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.: SG&A Expense Trends
Viking Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?